Intravenous Infusions is trading 3.57% down now at $0.54 based on supplied price context for September 17, 2026, with no credible company-specific announcement or new filing identified to explain the decline.
- The Ghana Stock Exchange’s latest listed notices through September 15 did not include Intravenous Infusions.
- The broader market backdrop was positive on September 17, 2026, so the decline cannot be confidently attributed to broad risk-off sentiment.